Results 61 to 67 of about 445 (67)

Neoadjuvant modified FOLFIRINOX plus nivolumab in borderline-resectable pancreatic ductal adenocarcinoma: a pilot phase 1 trial. [PDF]

Nat Commun
Wainberg ZA, Link JM, Premji A, Zheng S, Srienc M, Hammons M, Kim SE, Li L, Liu Z, Tsvetkova O, Abt ER, Rosen L, Kim S, King J, Hines OJ, Girgis M, Sadeghi S, Olevsky O, Wong D, Yonemoto L, Siney AM, Kelly K, Kivork C, Tseng CH, Radu CG, Dawson DW, Donahue TR.   +26 more
europepmc   +1 more source

Copper homeostasis and cuproptosis rewire the tumor microenvironment: mechanisms, immune modulation, and therapeutic opportunities. [PDF]

J Hematol Oncol
Li G, Wang W.
europepmc   +1 more source

Issues Relative to the Welding of Nickel and Its Alloys. [PDF]

Materials (Basel)
Rylski A, Siczek K.
europepmc   +1 more source

Delivery of Adeno-Associated Virus Vectors to the Central Nervous System for Correction of Single Gene Disorders. [PDF]

Int J Mol Sci
Daci R, Flotte TR.
europepmc   +1 more source

Cancer stem cell plasticity: mechanisms, immune microenvironment crosstalk, and therapeutic implications. [PDF]

J Hematol Oncol
Tan J, Wen T, Liu J, Ru X.
europepmc   +1 more source

Molecular Underpinning of Treatment-Resistant Schizophrenia: A Putative Different Neurobiology from Treatment-Responsive Schizophrenia. [PDF]

Int J Mol Sci
Barone A, Vellucci L, Ciccarelli M, Matrone M, De Simone G, Iannotta F, Iasevoli F, de Bartolomeis A.   +7 more
europepmc   +1 more source

Dual NIR-I excitation and emission-based thermometry and pH-responsive drug delivery using NaYF₄:Yb,Er@SiO₂-folic acid conjugates.

J Mater Chem B
Mohanty S, Machado IP, García-Balduz J, Premcheska S, Skirtach A, Van Hecke K, Kaczmarek AM.   +6 more
europepmc   +1 more source